TRANSCEND trial data of novel CAR T cell therapy introduced

Data from the TRANSCEND trial of JCAR017 in relapsed and refractory aggressive B cell non-Hodgkin lymphoma (NHL) was introduced on June 17th at the two thousand seventeen International Conference on Malignant Lymphoma in Lugano, Switzerland. Read more